|
1
|
Matsuda A and Matsuda T: Time trends in
stomach cancer mortality (1950–2008) in Japan, the USA and Europe
based on the WHO mortality database. Jpn J Clin Oncol. 41:932–933.
2011.
|
|
2
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar
|
|
3
|
Yokota T, Ishiyama S, Saito T, et al:
Lymph node metastasis as a significant prognostic factor in gastric
cancer: a multiple logistic regression analysis. Scand J
Gastroenterol. 39:380–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen JH, Wu CW, Lo SS, et al: Lymph node
metastasis as a single predictor in patients with Borrmann type I
gastric cancer. Hepatogastroenterology. 54:981–984. 2007.PubMed/NCBI
|
|
5
|
Saito H, Fukumoto Y, Osaki T, et al:
Prognostic significance of level and number of lymph node
metastases in patients with gastric cancer. Ann Surg Oncol.
14:1688–1693. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sano T and Aiko T: New Japanese
classifications and treatment guidelines for gastric cancer:
revision concepts and major revised points. Gastric Cancer.
14:97–100. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonenkamp JJ, Songun I, Hermans J, et al:
Randomised comparison of morbidity after D1 and D2 dissection for
gastric cancer in 996 Dutch patients. Lancet. 345:745–748. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cuschieri A, Fayers P, Fielding J, et al:
Postoperative morbidity and mortality after D1 and D2 resections
for gastric cancer: preliminary results of the MRC randomised
controlled surgical trial. The Surgical Cooperative Group. Lancet.
347:995–999. 1996. View Article : Google Scholar
|
|
9
|
Degiuli M, Sasako M, Ponti A, Soldati T,
Danese F and Calvo F: Morbidity and mortality after D2 gastrectomy
for gastric cancer: results of the Italian Gastric Cancer Study
Group prospective multicenter surgical study. J Clin Oncol.
16:1490–1493. 1998.
|
|
10
|
Seevaratnam R, Cardoso R, McGregor C, et
al: How useful is preoperative imaging for tumor, node, metastasis
(TNM) staging of gastric cancer? A meta-analysis. Gastric Cancer.
Aug 12–2011.(E-pub ahead of print).
|
|
11
|
Ganpathi IS, So JB and Ho KY: Endoscopic
ultrasonography for gastric cancer: does it influence treatment?
Surg Endosc. 20:559–562. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yoshioka T, Yamaguchi K, Kubota K, et al:
Evaluation of 18F-FDG PET in patients with advanced,
metastatic, or recurrent gastric cancer. J Nucl Med. 44:690–699.
2003.PubMed/NCBI
|
|
13
|
Ha TK, Choi YY, Song SY and Kwon SJ:
F18-fluorodeoxyglucose-positron emission tomography and computed
tomography is not accurate in preoperative staging of gastric
cancer. J Korean Surg Soc. 81:104–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Natsugoe S, Mueller J, Stein HJ, Feith M,
Hofler H and Siewert JR: Micrometastasis and tumor cell
microinvolvement of lymph nodes from esophageal squamous cell
carcinoma: frequency, associated tumor characteristics, and impact
on prognosis. Cancer. 83:858–866. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kojima N, Yonemura Y, Bando E, et al:
Optimal extent of lymph node dissection for T1 gastric cancer, with
special reference to the distribution of micrometastasis, and
accuracy of preoperative diagnosis for wall invasion.
Hepatogastroenterology. 55:1112–1117. 2008.PubMed/NCBI
|
|
16
|
Motoyama K, Inoue H, Mimori K, et al:
Clinicopathological and prognostic significance of PDCD4 and
microRNA-21 in human gastric cancer. Int J Oncol. 36:1089–1095.
2010.PubMed/NCBI
|
|
17
|
Tanaka M, Kitajima Y, Edakuni G, Sato S
and Miyazaki K: Abnormal expression of E-cadherin and beta-catenin
may be a molecular marker of submucosal invasion and lymph node
metastasis in early gastric cancer. Br J Surg. 89:236–244.
2002.PubMed/NCBI
|
|
18
|
Arigami T, Natsugoe S, Uenosono Y, et al:
CCR7 and CXCR4 expression predicts lymph node status including
micrometastasis in gastric cancer. Int J Oncol. 35:19–24. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Z, Ye Y, Dong L, et al: Kindlin-2: a
novel adhesion protein related to tumor invasion, lymph node
metastasis, and patient outcome in gastric cancer. Am J Surg.
203:222–229. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bibikova M, Barnes B, Tsan C, et al: High
density DNA methylation array with single CpG site resolution.
Genomics. 98:288–295. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oka D, Yamashita S, Tomioka T, et al: The
presence of aberrant DNA methylation in noncancerous esophageal
mucosae in association with smoking history: a target for risk
diagnosis and prevention of esophageal cancers. Cancer.
115:3412–3426. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Niwa T, Tsukamoto T, Toyoda T, et al:
Inflammatory processes triggered by Helicobacter pylori
infection cause aberrant DNA methylation in gastric epithelial
cells. Cancer Res. 70:1430–1440. 2010.
|
|
23
|
Niwa T, Yamashita S, Tsukamoto T, et al:
Whole-genome analyses of loss of heterozygosity and methylation
analysis of four tumor-suppressor genes in
N-methyl-N′-nitro-N-nitrosoguanidine-induced rat stomach
carcinomas. Cancer Sci. 96:409–413. 2005.PubMed/NCBI
|
|
24
|
Zheng Y, Cohen-Karni D, Xu D, et al: A
unique family of Mrr-like modification-dependent restriction
endonucleases. Nucleic Acids Res. 38:5527–5534. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cohen-Karni D, Xu D, Apone L, et al: The
MspJI family of modification-dependent restriction endonucleases
for epigenetic studies. Proc Natl Acad Sci USA. 108:11040–11045.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yokota T, Ishiyama S, Saito T, et al: Is
tumor size a prognostic indicator for gastric carcinoma? Anticancer
Res. 22:3673–3677. 2002.PubMed/NCBI
|
|
27
|
Simon R, Radmacher MD, Dobbin K and
McShane LM: Pitfalls in the use of DNA microarray data for
diagnostic and prognostic classification. J Natl Cancer Inst.
95:14–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
